US2008153124A1PendingUtilityA1
Methods for improving the function of heterlogous G protein-coupled receptors
Est. expirySep 1, 2018(expired)· nominal 20-yr term from priority
G01N 33/566C07K 14/705G01N 2333/726G01N 2500/10
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates to mutant G protein-coupled receptors with improved G-protein coupling and receptor response, yeast cells expressing such receptors, vectors useful for making such cells, and methods of making and using same.
Claims
exact text as granted — not AI-modified1 - 38 . (canceled)
39 . A yeast cell comprising a heterologous G protein-coupled receptor, wherein, the heterolocous the G protein-coupled receptor has a deletion in an intracellular domain that results in an improved functional response of the heterologous G protein-coupled receptor in a cell-based assay as compared to a wild-type form of the heterologous G protein-coupled receptor.
40 . The yeast cell according to claim 39 , wherein the modification promotes agonist stimulated growth, and wherein the agonist is a G protein-coupled receptor agonist.
41 . The yeast cell according to claim 40 , wherein the modification results in improved coupling between the heterologous G protein-coupled receptor and a heterotrimeric G protein or failure of the heterologous G protein-coupled receptor to interact with cell desensitization or sequestration-internalization machinery or proper plasma membrane localization.
42 . The yeast cell according to claim 39 , wherein the heterologous G protein-coupled receptor is modified at the carboxy terminal tail of the heterologous G protein-coupled receptor.
43 . The yeast cell according to claim 42 , wherein the modified heterologous G protein-coupled receptor is a neurotensin receptor.
44 . The yeast cell according to claim 43 , wherein the neurotensin receptor is a rat neurotensin NT1 receptor.
45 . A method for screening compounds capable of binding to G protein-coupled receptors comprising:
(a) subjecting the yeast cell according to claim 39 to a test compound; and (b) measuring the effect of the test compound on yeast cell growth.Join the waitlist — get patent alerts
Track US2008153124A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.